| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700177 | Clinical Oncology | 2009 | 7 Pages |
Abstract
Continuous infusional 5-fluorouracil has activity in transitional cell carcinoma of the urinary tract. Prolonged fluoropyrimidine administration may be a useful component of future combination regimens for this disease, particularly in patients with poor renal function.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.S. Highley, G.O. Griffiths, B.M. Uscinska, R.A. Huddart, J.B.P. Barber, M.K.B. Parmar, P.G. Harper, on behalf of the NCRI Bladder Cancer Clinical Studies Group on behalf of the NCRI Bladder Cancer Clinical Studies Group,